Robust Three-dimensional Tools to Design Inhibitors Against Drug Targets Which Lack Explicit Specificity
Dr. Moses Mohandas Prabu, The Commonwealth Medical College, speaking at Discovery Chemistry Congress 2013.
Chemical Proteomics: Drug Targets, Drug Selectivity, MoA and Resistance
Dr. Guillaume Médard, Technische Universität München, speaking at Discovery Chemistry Congress 2013.
Detection of Rare Cancer Cell Phenotypes by Single Cell Analysis of Surface Proteins
Rajan Kumar, Genome Data Systems, Inc., speaking at Lab-on-a-Chip World Congress 2012
Regulation of antibody immunotherapy by fine-tuning FcR interactions
Mark Cragg, Southampton University School of Medicine, speaking at Stem Cells & Bioprocessing 2012.
A Linear Array of Unique Microfluidic Gradients for Enzymatic Bioassay
Matthew Estes, University of Arizona, speaking at Lab-on-a-Chip World Congress 2012
Dynamics of Sex Chromosome Activity During Gametogenesis
Willy Baarends, Group Leader, speaking at Genomics Research Europe 2012
Exploiting New Knowledge in Metabolic and Stress Signalling: Contribution to Achieving the Goal of 20:20 Wheat
Nigel Halford, Rothamsted Research, speaking at Genomics Research Europe 2012
The Use of -omic Technologies for Biomarker Development
Michael Pfaffl, Principal Investigator, Technical University of Munich, speaking at Genomics Research Asia 2012
Immunogenicity Assessment for the Successful Development of Biosimilars
Dr Michael Tovey, Institut Andre Lwoff/INSERM, speaking at Stem Cells & Bioprocessing 2012.